Literature DB >> 2569022

Effects of adrenergic agents on alpha-chymotrypsin-induced ocular hypertension in albino and pigmented rabbits: a comparative study.

J Himber1, G de Burlet, G Andermann.   

Abstract

Alpha-chymotrypsin-induced ocular hypertension in albino rabbits is widely used as an experimental model to screen potential antiglaucoma drugs. The present study compares the intraocular pressure (IOP) response following the ocular application of single or repeated adrenergic agents in conscious albino and pigmented rabbits. A single instillation of clonidine was not as effective in lowering the IOP in pigmented hypertensive rabbit eyes as in albino hypertensive eyes. Similarly, betaxolol moderately lowered the IOP in albino rabbits but induced a slight response when pigmented rabbits were used as an experimental model. Twice-a-day applications of betaxolol in pigmented hypertensive eyes permitted an identical level of IOP decrease to be reached, as observed in a one-day study in albino rabbits, after at least 6 days of treatment. It has been suggested that the pigmented layers of the iris-ciliary body may act as sites for topically applied antiglaucoma drugs. Non-specific binding could explain in part the frequent discrepancy observed between the preclinical results obtained in albino hypertensive rabbit eyes and clinical results obtained in glaucomatous human eyes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569022     DOI: 10.1089/jop.1989.5.93

Source DB:  PubMed          Journal:  J Ocul Pharmacol        ISSN: 8756-3320


  3 in total

1.  Sustained release ocular inserts of brimonidine tartrate for better treatment in open-angle glaucoma.

Authors:  Prakash Bhagav; Vaibhav Trivedi; Darshan Shah; Sajeev Chandran
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

2.  Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.

Authors:  Prakash Bhagav; Hariom Upadhyay; Sajeev Chandran
Journal:  AAPS PharmSciTech       Date:  2011-08-31       Impact factor: 3.246

3.  Design, optimisation and evaluation of in situ gelling nanoemulsion formulations of brinzolamide.

Authors:  Hemant Bhalerao; K B Koteshwara; Sajeev Chandran
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.